On September 8, UBS lifted its price target on Northrop Grumman Corporation (NYSE:NOC) to $704 from $685, while maintaining a Buy rating on the shares.
The new price target represented an upside of 36% at the time of the note. According to a report on TipRanks, the firm told investors that the raise reflects a slightly higher industry-wide multiple for primes.
Photo by Arturo Añez on Unsplash
While not related, the adjustment came the day the company was awarded a $4.84 billion Army contract for the production of the Common Infrared Countermeasure (CIRCM) system.
Wall Street’s Consensus View
As of the close of business on September 14, Northrop Grumman Corporation is a Moderate Buy based on the recommendations from 16 analysts.
The stock has a one-year average share price target of $641.93, representing an upside potential of 21.72%.
Bull Case
Northrop Grumman Corporation’s Q2 results gave UBS plenty of reasons to justify its bullish position. The defense contractor beat estimates for both sales and profit, and lifted its full-year outlook. It ended the quarter with a record backlog of $105 billion, with new awards of $20 billion.
The case is also backed by the macro setup. With no end to the Ukraine-Russia war in sight and the Middle East conflict intensifying, structural tailwinds with respect to rising global military expenditure are likely to sustain demand for the coming quarters.
The $4.84 billion Army contract for the Common Infrared Countermeasure (CIRCM) system underscores this dynamic of rising demand resulting in multi-year revenue. The deal runs through September 2035.
Another layer to the bull thesis is NOC’s valuation. It has a forward price-to-earnings ratio of 17.90. This is below the sector median of 19.63, and below those of peers such as GD and RTX, signaling that the stock is trading at a discount. This allows room for the multiple expansion that UBS has based its $704 price target on.
Bear Case
The price target set by UBS is based on a higher sector-wide multiple for Primes, rather than Northrop Grumman Corporation’s fundamentals, which makes it vulnerable to any future sentiment shift away from defense stocks.
Despite beating estimates in Q2, two of the company’s four business segments faced a decline in operating income during the quarter, giving skeptics reason to question whether NOC deserves that higher multiple like its peers. Moreover, analysts at JP Morgan and TD Cowen noted that the earnings beat in Q2 was driven mainly by a lower tax rate.
The company is also facing cost pressures in programs such as the GEM 63XL and SiAW. Rising capital expenditure is also beginning to weigh on free cash flow. This was cited as one of the reasons behind the stock’s underperformance by The London Company Income Equity Strategy in its Q2 2026 investor letter.
Hedge Fund Ownership Trends
According to Insider Monkey, 59 hedge funds held a stake in Northrop Grumman Corporation at the end of the second quarter. This is a slight decline from 62 funds in Q1.
Citadel Investment Group was the largest stakeholder in the company, with shares worth $289 million as of June 30. D E Shaw was second with holdings of $224 million, followed by AQR Capital Management in third with $219 million.
Closing Take
UBS is betting on the sector, not just NOC itself. The increased price target is built on sector multiples, rather than the company’s fundamentals. Moreover, Wall Street’s consensus price target still lags behind UBS’s forecast, suggesting that the market has not fully embraced the thesis yet. That said, it is a bet worth watching closely. The defense contractor is expected to report Q3 earnings after mid-October, and that will determine whether the $704 price target holds up.
READ NEXT: NOC Steady at $2.47: A Closer Look at Northrop Grumman Corporation (NOC)’s Dividend Discipline and Is General Dynamics Corporation (GD) Still a Dividend Powerhouse? The Bull and Bear Case
